CN101491663A - Traditional Chinese medicine composition for treating various cancer - Google Patents
Traditional Chinese medicine composition for treating various cancer Download PDFInfo
- Publication number
- CN101491663A CN101491663A CNA2009100584577A CN200910058457A CN101491663A CN 101491663 A CN101491663 A CN 101491663A CN A2009100584577 A CNA2009100584577 A CN A2009100584577A CN 200910058457 A CN200910058457 A CN 200910058457A CN 101491663 A CN101491663 A CN 101491663A
- Authority
- CN
- China
- Prior art keywords
- grams
- rhizoma
- radix
- chinese medicine
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention provides a traditional Chinese medicine composition for treating a plurality of cancers. 37 traditional Chinese medicine components such as night shade seeds, Shouguan, airpotato yam, Indian iphigenia bulb, Chinese Paris rhizome, herba patriniae, blister beetles, herba scutellariae barbatae, oldenlandia diffusa, zedoary, glossy privet fruit, dung beetles and trichosanthis fructus are subjected to impurity removal respectively, dried, mixed and ground so as to prepare the composition. The composition is characterized in that the composition completely selects a pure natural medicinal formulation, is prepared through a traditional process, and has the functions of regulating the immunity of human bodies, strengthening the metabolic activity of the human bodies, killing cancer cells, protecting normal healthy organism cells and promoting rehabilitation after diseases. The composition is applicable to the clinical treatment of different tumors, particularly liver cancer, lung cancer, esophagus cancer, gastric cancer and the like, has the effective rate of 94.7 percent and the cure rate of 86 percent, and has the effects of no metastasis and no relapse.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of multiple cancer.
Background technology
Cancer is a kind of disease of serious harm human health, and its sickness rate is higher.Human at present to its real pathogeny clear understanding not also.Treatment of cancer at present is world's difficult problem, current Therapeutic Method has methods such as operation, radiotherapy, chemotherapy, these therapies are being killed, are also being destroyed normal histiocyte in the anticancer growth, the shortcoming that also toxic side effect is big, medical expense is high, often quicken the cancer cell metastasis diffusion, shortened patient's life span, the major injury patient body.The utilization of tcm therapy is arranged in the clinical practice, but present tcm therapy only is that the part cancer is had certain curative effect.
Summary of the invention
The problem to be solved in the present invention is to provide a kind of Chinese medicine composition for the treatment of multiple cancer.Its toxic and side effects is little, and is cheap, and the cure rate height does not recur after healing.
The raw material of Chinese medicine composition of the present invention is formed and weight proportion is:
Herba Scutellariae Barbatae 85-90; Herba Hedyotidis Diffusae 85-90; Rhizoma Polygoni Cuspidati 85-90; Radix Scutellariae 85-95; Herba Patriniae 85-90; Eupolyphaga Seu Steleophaga 55-60; Fructus Ligustri Lucidi 55-65; Fructus Solani Nigri 55-60; Rhizoma Curcumae 55-60; Rhizoma Cyperi 45-55; Bulbus Fritillariae Cirrhosae 45-55; Semen Coicis 45-55; Radix Isatidis 45-50; Radix Astragali 45-55; YALIAN 45-50; Ganoderma 45-55; Herba Lysimachiae 45-50; The real 45-55 of Fructus Trichosanthis; Rhizoma Dioscoreae Bulbiferae 25-30; Rhizoma sparganic 25-30; Semen Armeniacae Amarum 25-35; Gold Testudinis lotus 25-30; Thallus Laminariae (Thallus Eckloniae) 25-35; Sargassum 25-35; Lignum Aquilariae Resinatum 25-35; Radix Trichosanthis 25-30; Gekko Swinhonis 25-30; Semen Impatientis 25-30; Radix Salviae Miltiorrhizae 25-30; Radix Ginseng 25-35; Stir-baked SQUAMA MANITIS 15-20; Catharsii molossi 15-20; Gecko 45-55; Cordyceps 5-15; Mylabris 5-10; Rhizoma Paridis 5-10; Pseudobulbus Cremastrae Seu Pleiones 5-10.
Processing method:, promptly make powdered Chinese medicine composition with 37 flavor Chinese medicinal components roguings respectively, drying, mixing, the pulverizing of above-mentioned weight proportion.Above-mentioned Chinese medicine composition directly can be made pill, or adopt conventional processing mode to make multiple dosage forms such as sublimed preparation, tablet, dissolved granule, powder, oral liquid, syrup.A kind of method is with powdered Chinese medicine composition flooding, can get effective ingredient after the drying.Effective ingredient also can adopt other suitable method to extract certainly.Incapsulate standby by 0.25 every of gram the effective ingredient of above-mentioned processing gained.Usage and dosage: be grown up three times on the one, a 4-5 grain generally is no more than 5.One month is a course of treatment, general recovery from illness 3-4 the course of treatment.
We can strengthen immune function of human body according to the principle of traditional Chinese medical science strengthening vital QI to eliminate pathogenic factors, suppress tumor growth.Ten flavor principal agents such as the Fructus Solani Nigri of the cancerous cell killed that we's employing is with strong points, Gekko Swinhonis, Rhizoma Dioscoreae Bulbiferae, Pseudobulbus Cremastrae Seu Pleiones, Rhizoma Paridis, Herba Patriniae, Mylabris, Herba Scutellariae Barbatae, Herba Hedyotidis Diffusae, Rhizoma Curcumae are monarch; To have seven flavor Chinese medicines such as reinforcing body resistance, raising resistance, the Fructus Ligustri Lucidi of strengthening protective potential, the Radix Astragali, Bulbus Fritillariae Cirrhosae, Ganoderma, Gecko, Radix Ginseng, Cordyceps is minister; Auxiliary to strengthen 12 flavor Chinese medicines such as the Catharsii molossi of killing function, stir-baked SQUAMA MANITIS, Semen Impatientis, Radix Trichosanthis, Radix Salviae Miltiorrhizae, Rhizoma Polygoni Cuspidati, Eupolyphaga Seu Steleophaga, Radix Isatidis, Gold Testudinis lotus, Herba Lysimachiae, YALIAN, rhizoma sparganic be assistant to have; For making, all guiding drugs are directed at collaterals of human, internal organs with eight flavor Chinese medicines such as Fructus Trichosanthis reality, Semen Coicis, Radix Scutellariae, Rhizoma Cyperi, Lignum Aquilariae Resinatum, Thallus Laminariae (Thallus Eckloniae), Sargassum, Semen Armeniacae Amarum, bring into play its powerful therapeutical effect.We have targeting accurately, use through inventor's many decades routine patients clinical surplus the ground 2000 such as Nanchong, Sichuan, Guangyuan, have unique significant curative effect.
The major advantage of this Chinese medicine composition:
1, evident in efficacy and instant effect.Generally promptly take effect in one week of medication, as show as: pain relief, appetite increase, spirit takes a turn for the better; Patients with lung cancer cough, hemoptysis obviously go down.After two weeks of medication, cachexia body constitution is obviously improved, and along with appetite increases, spirit takes a turn for the better, and body weight also increases gradually, and mobility strengthens.2, the patient who cures through this side does not see the recidivist as yet.3, have no side effect substantially.4, drug price is low, has alleviated patient's financial burden greatly, cost saving about 60%.
The inventor improves and is a disciple of secret recipe, through many decades clinical treatment practice, is developed into pharmaceutical composition of the present invention.The appropriate compatibility of drugs of pharmaceutical composition of the present invention and dosage demonstrate its original effect, and can cure general 3-4 the course of treatment (3 to April), and its short treating period, expense are low.Since in 1972, gone through the clinical practice in year surplus in the of 30, the inventor is the people surplus the various cancer patients 2000 of Drug therapy of the present invention, and total effective rate reaches 94.7%, cure rate 86%, and criterion of therapeutical effect and relevant treatment situation statistics are as follows:
Criterion of therapeutical effect
Curative effect | Symptom | Sign | Inspections such as CT, section, chemical examination |
Recovery from illness | Complete obiteration | Positive sign disappears | Every index is normal |
Produce effects | Basic disappearance focus is dwindled | Positive sign 90% disappears, and all the other are turned out cloudy | Every index takes a turn for the better |
Effectively | Obviously alleviate, focus is basicly stable | Positive sign is turned out cloudy substantially | Every index is stable |
Invalid | Do not disappear |
Therapeutic effect situation statistical table
Cure case:
Case one: Zhao so-and-so, man, 73 years old now, live seven groups in cypress Yangchuan village, mesa township, Langzhong City, Sichuan, the bimester of retrosternal pain, be diagnosed as esophageal carcinoma in Sichuan medical college barium meal examination in April, 1972, the treatment January after invalid returning home, continuously stupor is three days, prepares abandoning cure, and May in the same year, its household asked me to go to patient's family to keep to examine, with Drug therapy of the present invention after 3 days the patient revive, continue treatment and can drink porridge in one week, three months (3 courses of treatment), the back rehabilitation was very healthy so far.In December, 2008 is investigated on the spot, call oneself 30 surplus year flu trouble seldom all.
Case two: Zhang, the man, 72 years old now, live six groups in three villages, Ilicis Purpureae district, Guangyuan City Cangxi County, Sichuan, be diagnosed as gastric cancer through the gastroscopy of the People's Hospital, Cangxi County in March, 1984, require operative treatment, go to a doctor after the people is illustrated in April in the same year here, with our medicine after one week, stomachache, flatulence, symptom such as become thin obviously change, treatment returns to one's perfect health three months (3 courses of treatment) continuously, now not recurrence in 24 years.
Case three: the week so-and-so, man, 63 years old now, live three groups in Liu Xi village, Jin Bi township, Guangyuan City Cangxi County, Sichuan, be hepatocarcinoma through the CT of Nanchong City the People's Hospital, color ultrasonic diagnosis in May, 1996, and disease is seen swelling under the right rib, pain, palpation liver matter is harder, the nodal-like lump, touch a tender spot, the colour of the tongue purple is felt dizzy, blurring of vision, the appetite extreme difference is seriously detested oil, vomiting, cachexia.Go to a doctor to here in the back, with one week of our medicine the back symptom basicly stable, slightly alleviate, above-mentioned symptoms alleviate after two weeks of medication, medication three all appetite improvements, medication spirit in January takes a turn for the better, and treats recovery from illness in four months continuously, 12 years so far, is in a good state of health.
Case four: grandson so-and-so, woman, 48 years old now, live three groups in Ban Miao village, Zhong Tu township, Guangyuan City Cangxi County, Sichuan, because of left breast swells and ache, enclosed mass is grown up gradually, in JIUYUE, 2002 is a breast carcinoma through the People's Hospital, Cangxi County biopsy diagnosis, return home because of being reluctant to be treated surgically, after come here treatment upon somebody's introduction, with we's one week of treatment, symptom is stable, spirit takes a turn for the better, three months (three courses of treatment) of medication, through the complete obiteration of check lump, not recurrence in 5 years so far.
The specific embodiment
Further the present invention will be described below in conjunction with specific embodiment.
A kind of Chinese medicine composition for the treatment of multiple cancer is that the composition of pressing column weight amount proportioning is chosen: Herba Scutellariae Barbatae 90 grams; Herba Hedyotidis Diffusae 90 grams; Rhizoma Polygoni Cuspidati 90 grams; Radix Scutellariae 90 grams; Herba Patriniae 90 grams; Eupolyphaga Seu Steleophaga 60 grams; Fructus Ligustri Lucidi 60 grams; Fructus Solani Nigri 60 grams; Rhizoma Curcumae 60 grams; Rhizoma Cyperi 50 grams; Bulbus Fritillariae Cirrhosae 50 grams; Semen Coicis 50 grams; Radix Isatidis 50 grams; The Radix Astragali 50 grams; YALIAN 50 grams; Ganoderma 50 grams; Herba Lysimachiae 50 grams; Real 50 grams of Fructus Trichosanthis; Rhizoma Dioscoreae Bulbiferae 30 grams; Rhizoma sparganic 30 grams; Semen Armeniacae Amarum 30 grams; Gold Testudinis lotus 30 grams; Thallus Laminariae (Thallus Eckloniae) 30 grams; Sargassum 30 grams; Lignum Aquilariae Resinatum 30 grams; Radix Trichosanthis 30 grams; Gekko Swinhonis 30 grams; Semen Impatientis 30 grams; Radix Salviae Miltiorrhizae 30 grams; Radix Ginseng 30 grams; Stir-baked SQUAMA MANITIS 20 grams; Catharsii molossi 20 grams; Gecko 50 grams; Cordyceps 10 grams; Mylabris 10 grams; Rhizoma Paridis 10 grams; Pseudobulbus Cremastrae Seu Pleiones 10 grams.With 37 flavor Chinese medicinal components roguings respectively, drying, mixing, the pulverizing of above-mentioned weight proportion, promptly make this Chinese medicine composition.Above-mentioned Chinese medicine composition flooding can be able to be got effective ingredient after the drying.Effective ingredient also can adopt other suitable common method to extract.Incapsulate standby by 0.25 every of gram the effective ingredient of above-mentioned processing gained.Usage and dosage: be grown up three times on the one, a 4-5 grain generally is no more than 5.One month is a course of treatment, general recovery from illness 3-4 the course of treatment.
Claims (2)
1, a kind of Chinese medicine composition for the treatment of multiple cancer is characterized in that the Chinese medicine ingredients that comprises that following weight proportion is:
Herba Scutellariae Barbatae 85-90; Herba Hedyotidis Diffusae 85-90; Rhizoma Polygoni Cuspidati 85-90; Radix Scutellariae 85-95; Herba Patriniae 85-90; Eupolyphaga Seu Steleophaga 55-60; Fructus Ligustri Lucidi 55-65; Fructus Solani Nigri 55-60; Rhizoma Curcumae 55-60; Rhizoma Cyperi 45-55; Bulbus Fritillariae Cirrhosae 45-55; Semen Coicis 45-55; Radix Isatidis 45-50; Radix Astragali 45-55; YALIAN 45-50; Ganoderma 45-55; Herba Lysimachiae 45-50; The real 45-55 of Fructus Trichosanthis; Rhizoma Dioscoreae Bulbiferae 25-30; Rhizoma sparganic 25-30; Semen Armeniacae Amarum 25-35; Gold Testudinis lotus 25-30; Cloth 25-35; Sargassum 25-35; Lignum Aquilariae Resinatum 25-35; Radix Trichosanthis 25-30; Gekko Swinhonis 25-30; Semen Impatientis 25-30; Radix Salviae Miltiorrhizae 25-30; Radix Ginseng 25-35; Stir-baked SQUAMA MANITIS 15-20; Catharsii molossi 15-20; Gecko 45-55; Cordyceps 5-15; Mylabris 5-10; Rhizoma Paridis 5-10; Pseudobulbus Cremastrae Seu Pleiones 5-10.
2, a kind of Chinese medicine composition for the treatment of multiple cancer according to claim 1 is characterized in that the Chinese medicine ingredients that comprises that following weight proportion is:
Herba Scutellariae Barbatae 90 grams; Herba Hedyotidis Diffusae 90 grams; Rhizoma Polygoni Cuspidati 90 grams; Radix Scutellariae 90 grams; Herba Patriniae 90 grams; Eupolyphaga Seu Steleophaga 60 grams; Fructus Ligustri Lucidi 60 grams; Fructus Solani Nigri 60 grams; Rhizoma Curcumae 60 grams; Rhizoma Cyperi 50 grams; Bulbus Fritillariae Cirrhosae 50 grams; Semen Coicis 50 grams; Radix Isatidis 50 grams; The Radix Astragali 50 grams; YALIAN 50 grams; Ganoderma 50 grams; Herba Lysimachiae 50 grams; Real 50 grams of Fructus Trichosanthis; Rhizoma Dioscoreae Bulbiferae 30 grams; Rhizoma sparganic 30 grams; Semen Armeniacae Amarum 30 grams; Gold Testudinis lotus 30 grams; Thallus Laminariae (Thallus Eckloniae) 30 grams; Sargassum 30 grams; Lignum Aquilariae Resinatum 30 grams; Radix Trichosanthis 30 grams; Gekko Swinhonis 30 grams; Semen Impatientis 30 grams; Radix Salviae Miltiorrhizae 30 grams; Radix Ginseng 30 grams; Stir-baked SQUAMA MANITIS 20 grams; Catharsii molossi 20 grams; Gecko 50 grams; Cordyceps 10 grams; Mylabris 10 grams; Rhizoma Paridis 10 grams; Pseudobulbus Cremastrae Seu Pleiones 10 grams.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910058457A CN101491663B (en) | 2009-02-26 | 2009-02-26 | Traditional Chinese medicine composition for treating various cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910058457A CN101491663B (en) | 2009-02-26 | 2009-02-26 | Traditional Chinese medicine composition for treating various cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101491663A true CN101491663A (en) | 2009-07-29 |
CN101491663B CN101491663B (en) | 2012-08-29 |
Family
ID=40922563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910058457A Expired - Fee Related CN101491663B (en) | 2009-02-26 | 2009-02-26 | Traditional Chinese medicine composition for treating various cancer |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101491663B (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102648956A (en) * | 2012-05-18 | 2012-08-29 | 漳州市中草药研究所 | Traditional Chinese herbal medicament for treating breast cancer and preparation method thereof |
CN102671079A (en) * | 2012-06-11 | 2012-09-19 | 谷洪田 | Medicine for treating liver cancer |
CN102727828A (en) * | 2012-06-29 | 2012-10-17 | 江苏省中医药研究院 | Traditional Chinese medicinal composition used for postoperative adjuvant therapy for colorectal cancer |
CN103316080A (en) * | 2013-07-10 | 2013-09-25 | 吴中区胥口精益生物医药研究所 | Special traditional Chinese medicine essence for preventing and treating benign laryngeal tumors and extraction process thereof |
CN103520652A (en) * | 2013-10-25 | 2014-01-22 | 马荣康 | Traditional Chinese medicine composition for treating liver cancer |
CN103520395A (en) * | 2013-10-25 | 2014-01-22 | 范银锁 | Traditional Chinese medicine composition for treating lung cancer |
CN103623199A (en) * | 2013-12-02 | 2014-03-12 | 李粤 | Traditional Chinese medicinal preparation for treating cancers and production method thereof |
CN105816669A (en) * | 2016-03-16 | 2016-08-03 | 司忠花 | Traditional Chinese medicine for treating respiratory tract cancer |
CN112370519A (en) * | 2020-12-07 | 2021-02-19 | 胡珍祥 | Composition for treating cancer, preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1327807A (en) * | 2000-06-12 | 2001-12-26 | 吴建华 | Chinese medicine for treating neoplasm |
-
2009
- 2009-02-26 CN CN200910058457A patent/CN101491663B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1327807A (en) * | 2000-06-12 | 2001-12-26 | 吴建华 | Chinese medicine for treating neoplasm |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102648956A (en) * | 2012-05-18 | 2012-08-29 | 漳州市中草药研究所 | Traditional Chinese herbal medicament for treating breast cancer and preparation method thereof |
CN102671079A (en) * | 2012-06-11 | 2012-09-19 | 谷洪田 | Medicine for treating liver cancer |
CN102727828A (en) * | 2012-06-29 | 2012-10-17 | 江苏省中医药研究院 | Traditional Chinese medicinal composition used for postoperative adjuvant therapy for colorectal cancer |
CN103316080A (en) * | 2013-07-10 | 2013-09-25 | 吴中区胥口精益生物医药研究所 | Special traditional Chinese medicine essence for preventing and treating benign laryngeal tumors and extraction process thereof |
CN103520652A (en) * | 2013-10-25 | 2014-01-22 | 马荣康 | Traditional Chinese medicine composition for treating liver cancer |
CN103520395A (en) * | 2013-10-25 | 2014-01-22 | 范银锁 | Traditional Chinese medicine composition for treating lung cancer |
CN103520395B (en) * | 2013-10-25 | 2015-04-08 | 唐清颖 | Traditional Chinese medicine composition for treating lung cancer |
CN103520652B (en) * | 2013-10-25 | 2015-04-22 | 陈静静 | Traditional Chinese medicine composition for treating liver cancer |
CN103623199A (en) * | 2013-12-02 | 2014-03-12 | 李粤 | Traditional Chinese medicinal preparation for treating cancers and production method thereof |
CN103623199B (en) * | 2013-12-02 | 2015-12-02 | 李粤 | A kind of Chinese medicine preparation of Therapeutic cancer and production method thereof |
CN105816669A (en) * | 2016-03-16 | 2016-08-03 | 司忠花 | Traditional Chinese medicine for treating respiratory tract cancer |
CN112370519A (en) * | 2020-12-07 | 2021-02-19 | 胡珍祥 | Composition for treating cancer, preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101491663B (en) | 2012-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101491663B (en) | Traditional Chinese medicine composition for treating various cancer | |
CN103041312B (en) | Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof | |
CN101249235B (en) | Chinese medicine for curing esophagus cancer and method of preparing the same | |
CN102008650B (en) | Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof | |
CN100460008C (en) | Chinese medicine composition for treating cancer | |
CN104352608A (en) | Traditional Chinese medicine capable of benefiting qi, activating blood circulation, softening hardness, dissipating stagnation, realizing detoxification and relieving pain as well as preparation method thereof | |
CN103585521B (en) | A kind of Chinese medicine composition being used for the treatment of dyspepsia, eating accumulation | |
CN102861193B (en) | Traditional Chinese medicine composition for treating gastric cancer | |
CN101091769B (en) | Medicine for treating and preventing esophagus cancer and gastric cancer, and preparation method | |
CN101537146B (en) | Chinese medicine for treating carcinoma of colon | |
CN102198226A (en) | Chinese herbal medicine composition for treating cancer | |
CN102755600B (en) | Traditional Chinese medicine compound for resisting breast cancer metastasis and reoccurrence, preparation method and uses | |
CN103933450A (en) | Traditional Chinese medicine composition for preventing or/and treating gastrointestinal diseases and preparation method of composition | |
CN104288631A (en) | Medicine composition for treating colon cancer and preparation method thereof | |
CN101391004B (en) | Medicine composition for treating late-stage esophageal carcinoma | |
CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
CN1050292C (en) | Anticancer drug and preparing method thereof | |
CN101513508A (en) | Chinese medicament for treating breast cancer, and preparation method thereof | |
CN101675961B (en) | A medicinal preparation for treating breast cancer and preparation method thereof | |
CN101204554B (en) | Medicaments composite for stomach illness and preparation method thereof | |
CN104888128A (en) | Traditional Chinese medicine composition for treatment of cancers | |
CN104324091A (en) | Traditional Chinese medicine formula for treating rectal cancer | |
CN1723956A (en) | Medicine for treating chronic gastritis and gastric carcinoma, and its prepn. method | |
CN1311851C (en) | Pill medicine for treating mastosis | |
CN1194717C (en) | Snake poison capsule for treating lung cancer and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120829 Termination date: 20160226 |